Drug recall · October 14, 2020
Citalopram Oral Solution recall
Why: Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40
- Lots / codes
Lots: C1EE Exp. 04/2021, BD82 Exp. 11/2020, BD83 Exp. 11/2020, C16D Exp. 02/2021, C563 Exp. 11/2021, C574 Exp. 11/2021
- Quantity
- 13480 cups
- Company
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc, Greenville, SC
- Distribution
- Nationwide.
- Initiated
- September 9, 2020 · Voluntary: Firm initiated
- Classified
- October 5, 2020
- Reported
- October 14, 2020
- Ended
- February 22, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Citalopram
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.